Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Carvedilol 12.5 mg vs Dilatrend in Healthy Thai Volunteers (Fasting)
TCTR20210219005Phase 1Not yet recruiting
- Sponsor
- Millimed
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of carvedilol (2 arms), sponsored by Millimed. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
carvedilol
Beyond the preview
Go deeper on TCTR20210219005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210219005.